| AKBM-14409/US-13/CON
`
`Re
`
`Application Number {DAW
`
`
`15180439 - GAU: 1851
`
`
`
`
`2016-06-13
`Filing Date
`
`Inge Bruheim
`First Named Inventor
`
`
`
`oEoo=Sj=SoSo©ounN=aoNOoNo—w_=oDoO>NO=aoOan=aaNONo~
`
`8344887
`
`8467794
`
`8486778
`
`B6 11222
`
`86/8317
`
`1996-08-14
`
`1992-02-25
`
`1994-07-19
`
`1997-07-08
`
`2003-08-05
`
`2003-10-31
`
`1997-08-05
`
`2005-05-20
`
`1992-01-17
`
`1986-12-11
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`—_
`
`No
`
`w
`
`—_h—_h—_h—_h~ab
`
`NoSo
`
`ho =
`
`EFS Web 2.1.17
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`AISHA LTD.
`
`AIYO FISHERY CO LTD
`
`HLORINE ENG CORP
`TD
`
`HLORINE ENG CORP
`TD
`
`KEDA SHOKKEN KK
`
`IPPON OIL & FATS CO
`
`REEN CROSS CORP
`
`HLORINE ENG CORP
`
`LECTRIC IND CO LTD
`
`SHISEIDO CO LTD;
`
`
`
`P001-158736
`
`2001-06-12
`
`SNOW BRAND MILK
`PROD CO LTD
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0401
`
`page 0401
`
`
`
`

`

`Re
`
`
`
`
`
`
`
`First Named Inventor Inge Bruheim
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`
`
`15180439 - GAU: 1851
`Application Number DAW
`
`
`
`
`2016-06-13
`Filing Date
`
`| AKBM-14409/US-13/CON
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`3oSw SoSoae —_= ta]No
`
`2003-01-08
`
`P003-048831
`
`2003-02-21
`
`P003-146883
`
`2003-05-21
`
`P005-245379
`
`2005-08-15
`
`P006-069948
`
`2006-03-16
`
`P006-083136
`
`2006-03-30
`
`P006-290784
`
`2006-10-26
`
`P006-316073
`
`2006-11-24
`
`P006-328014
`
`2006-12-07
`
`P007-126455
`
`2007-05-24
`
`P007-246404
`
`2007-08-27
`
`NoNo
`
`Now
`
`Boag
`
`NoNoNoNoNo=woco~aooa
`
`wSo
`
`ww
`
`wNo
`
`EFS Web 2.1.17
`
`NITIKA LTD
`
`SUNTORY LTD
`
`SNOW BRAND MILK
`PROD CO LTD
`
`AISHA LTD
`
`IROSE YUKIHIRO
`UJI CHEM IND CO LTD
`
`SUNTORY LTD
`
`IROSE YUKIHIRO
`
`BIOTECHNOLOGY
`RESEARCH LTD
`
`IROSE YUKIHIRO
`
`SNOW BRAND MILK
`PROD CO LTD
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0402
`
`page 0402
`
`

`

`15180439 - GAU: 1851
`Application Number DAW
`
`
`
`
`2016-06-13
`Filing Date
`
`
`
`First Named Inventor Inge Bruheim
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`
`
`| AKBM-14409/US-13/CON
`
`Re
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`
`
`=
`
`NoOo~]
`
`—
`
`Cc
`
`1971-01-06
`
`986/06082
`
`1986-10-23
`
`990/05765
`
`1990-05-31
`
`993/24142
`
`1993-12-09
`
`997/38585
`
`1997-10-23
`
`997/39759
`
`1997-10-30
`
`998/34498
`
`1998-08-13
`
`999/39589
`
`1999-08-12
`
`P000/23546
`
`2000-04-27
`
`P000/25608
`
`2000-05-11
`
`P000/38708
`
`2000-07-06
`
`wwo
`
`Wwng
`
`wwa
`
`fWwwWwWw=ooco~Qo
`
`a
`
`feBo
`
`aw
`
`EFS Web 2.1.17
`
`RGUCHKOV
`
`AT-CON RADGIVENDE
`
`NGENIGRFIRMA A/S
`
`IKALSEN
`
`PHAIRSON MEDICAL AB
`
`HE UNIVERSITY OF
`BRITISH COLUMBIA
`
`BRIGHAM AND
`
`ALOISE
`
`NIV SHERBROOKE
`
`PHAIRSON MEDICAL
`NC.
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0403
`
`page 0403
`
`

`

`cc
`
`IFOUGH
`
`/DW/
`
`15180439 - GAU: 1651
`
`Application Number
`Filing Date
`2016-06-13
` INFORMATION DISCLOSURE First Named Inventor|Inge Bruheim
`
`STATEMENT BY APPLICANT
`|...
`
` Attorney Docket Number
`
`
`
`
`
`
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`| AKBM-14409/US-13/CON
`
`«|— poZ -
`
`44
`
`2002-12-27
`
`oo
`
`45
`
`P003/011873
`
`2003-02-13
`
`BIORESSOURCESINC.
`
`
`
`eZ— _ oo
`
`49
`
`P007/080515
`
`2007-07-19
`
`AKER BIOMARINE ASA
`
`50
`
`D007/108702
`
`2007-09-27
`
`AKER SEAFOODS
`
`If you wish to add additional Foreign Patent Documentcitation information please click the Add button
`
`. .,_|Include nameof the author (in CAPITAL LETTERS),title of the article (when appropriate),title of the item
`
`Examiner] Cite
`_
`:
`:
`.
`ew
`(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`Initials
`No
`.
`:
`:
`publisher, city and/or country where published.
`
`
` Ts
`
`NON-PATENT LITERATURE DOCUMENTS
`
`ANDO and HATANO, 1988, “Isolation of apolipoproteins from carotenoid-carrying lipoprotein in the serum of chum
`Balmon, Oncorhynchusketa’, J. Lipid Research, 29: 1264-1271
`
`AOI et al., 2003, “Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice”, Antioxidants &
`edox Signaling, 5(1): 139-44
`
`
`
`
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0404
`
`page 0404
`
`

`

`
`Filing Date
`2016-06-13
`INFORMATION DISCLOSURE First Named Inventor|Inge Bruheim
`
`STATEMENT BY APPLICANT
`|...
`
`
`
`
`
`
`
`
`
`
`
`cc
`Application Number
`
`IFOUGH
`
`/DW/
`
`15180439 - GAU: 1651
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`Attorney Docket Number
`
`| AKBM-14409/US-13/CON
`
`
`No
`
`BRITTON, 1985, “General Carotenoid Methods’, Methods in Enzymology, Vol 111, pp. 113-149
`
`ALDER, 2006, “n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases”, Am. J. Clin. Nutr., 83:
`5058S
`
`HARESTetal., 2001, “Astaxanthin Extraction from Crawfish Shells by Supercritical CO2 with Ethanol as Cosolvent”,
`. Aquatic Food Product Technology, 10(3): 79-93
`
`HEN and MEYERS, 1982, “Extraction of Astaxanthin Pigment from Crawfish Waste Using a Soy Oil Process”, J.
`ood Sci., 47: 892-896
`
`LARKE, 1980, “The Biochemical Composition of Krill, Euphausia superba dana,from South Georgia”, J. Exp. Mar.
`iol. Ecol., 43: 221-236
`
`ZECZUGA,1974, “Comparative Studies of Carotenoidsin the Fauna of the Gullmar Fjord (Bohuslan, Sweden). II.
`rustacea: Eupagurus bernhardus, Hyas coarctatus and Upogebia deltaura’”, Marine Biology, 28: 95-98
`
`DE RITTER and PURCELL, 1981, “Carotenoid Analytical Methods”, Carotenoids as Colorants and Vitamin A
`Precursors: Technological and Nutritional Applications, pp 815-882
`
`DEUTCH, 1995, “Menstrual pain in Danish womencorrelated with low n-3 polyunsaturated fatty acid intake’, Eur. J.
`
`DIEZ et al., 2003, “The role of the novel adipocyte-derived hormone adiponectin in human disease”, Eur. J.
`ndocrinol., 148(3): 293-300
`
`LLINGSENet al., 1987, “Biochemistry of the autclytic processes in Antarctickrill post mortem. Autoproteolysis.”
`iochem. J. 246, 295-305
`
`= w
`
`MODI, 1978, “Carotenoids: Properties and Applications’, Food Technology, 32(5): 38
`
`EFS Web2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0405
`
`page 0405
`
`

`

`
`
`cc
`Application Number
`
`IFOUGH
`
`
`/DW/
`15180439 - GAU: 1651
`
`
`
`
`
`
`
`
`
`Filing Date
`2016-06-13
`INFORMATION DISCLOSURE First Named Inventor|Inge Bruheim
`
`STATEMENT BY APPLICANT
`|...
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`
`
`Examiner Name
`
`Attorney Docket Number
`
`| AKBM-14409/US-13/CON
`
`ntemational Search Report and Written Opinion for PCT/IB2010/000512; dated 2010-06-24
`
`—_h
`
`—_
`
`hoNo=So~
`
`oa
`
`=
`
`NoNo
`
`Now
`
`Boag
`
`EFS Web2.1.17
`
`ELIX-VALENZUELAetal., 2001, “Supercritical CO2/Ethanol Extraction of Astaxanthin from Blue Crab (Callinectes
`Sapidus) Shell Waste’, Journal of Food Process Engineering, 24: 101-112
`
`OX and SCHEER,1941, “Comparative Studies of the Pigments of Some Pacific Coast Echinoderms’, The Biological
`Bulletin, 441-455
`
`EUSENS etal., 1994, “Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-
`onth, double-blind, controlled study’, Arthritis Rheum., 37(6): 824-9
`
`ILCHRIST and GREEN, 1960, “The Pigments of Artemia”, Proceedings of the Royal Society, Series B Biological
`Sciences, Vol 152 No. 946, pp 118-136
`
`OQODWIN and SRISUKH, 1949, “Some Observations on Astaxanthin Distribution in Marine Crustacea’, Department
`of Biochemistry, University of Liverpool, pp. 268-270
`
`ULYAEV and BUGROVA,1976 “Removing fats from the protein paste “Okean”. Konservnaya | Ovoshchesushil’naya
`Promyshlennost, (4), 37-8
`
`IAARDARDOTTIR and KINSELLA, 1988, “Extraction of Lipid and Cholesterol from Fish Muscle with Supercritical
`luids” Journal of Food Science, 53(6)- 1656-1658
`
`NTERNATIONAL AQUA FEED, 2006, Vol. 9
`
`ntemational Search Report and Written Opinion for PCT/GB2008/002934, Dated 2009-03-11
`
`ntemational Search Report for PCT/IB2007/000098, dated: 2007-06-26
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0406
`
`page 0406
`
`

`

`
`
`cc
`Application Number
`
`IFOUGH
`
`/DW/
`
`15180439 - GAU: 1651
`
`Filing Date
`2016-06-13
`
`INFORMATION DISCLOSURE First Named Inventor|Inge Bruheim
`
`STATEMENT BY APPLICANT
`|...
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`
`
`
`
`Examiner Name
`
`Attorney Docket Number
`
`| AKBM-14409/US-13/CON
`
`
`
`
`Wwng
`
`Nooa
`
`Noao
`
`No~]
`
`wwwwNoNoNo=Sowoco
`
`ww
`
`ITOH et al., 2007; “Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of
`bbesity and human obese subjects’, Arteriosclerosis, Thrombosis, and Vascular Biology, 27(9)- 1918-1925
`
`OHNSONetal., 1978, “Simple Method for the Isolation of Astaxanthin from the Basidiomycetous Yeast Phaffia
`odozyma’”, Applied and Environmental Microbiology, 35(6): 1155-1159
`
`OLAKOWSKA, 1989, “Krill lipids after frozen storage of about one yearin relation to storage time before freezing”,
`ie Nahrung Food, 33(3): 241-244
`
`RIS-ETHERTON etal., 2002, “Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease”,
`irculation, 106:2747-2757
`
`RISTENSEN et al., 1989, “Dietary supplementation with n-3 polyunsaturated fatty acids and humanplatelet function:
`review with particular emphasis on implications for cardiovascular disease”, J. Intern. Med. Suppl. 731:141-50
`
`UNESOVAet al., 2006, “The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term
`eight reducing regimen on weight loss and serum fatty acid composition in severely obese women’, Physiol Res.; 55
`1):63-72
`
`AIGHTet al., 1999, “F2-isoprostane evidence of oxidantstressin the insulin resistant, obese Zucker rat: effects of
`itamin E”, Eur. J. Pharmacol. 377(1): 89-92
`
`AMBERTSONand BRAEKKAN, 1971, “Method of Analysis of Astaxanthin and its Occurrence in some Marine
`Products,” J. Sci. Food. Agr., Vol 22(2)- 99-101
`
`IBBYet al., 2006, “Inflammation and Atherothrombosis: From Population Biology and Bench Researchto Clinical
`Practice”, J. Amer. Coll. Card_, 48 (9, Suppl. A): A33-A46
`
`OPEZet al., 2004, “Selective extraction of astaxanthin from crustaceans by use of supercritical carbon dioxide”,
`alanta, 64: 726-731
`
`wwa
`
`AANDEVILLE, 1991, “Isolation and Identification of Carctenoid Pigments, Lipids and Flavor Active Components from
`Raw Commercial Shrimp Waste’, Food Biotechnology, 5(2): 185-195
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0407
`
`page 0407
`
`
`
`

`

`
`
`
`15180439 - GAU: 1851
`WEL
`cc
`
`Application Number
`
`
`Filing Date
`2016-06-13
`
`
`
`
`
` Attorney Docket Number
`
` | AKBM-14409/US-13/CON
`
`INFORMATION DISCLOSURE
`First Named Inventor|Inge Bruheim
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Art Unit
`
`Examiner Name
`
`EYERSand BLIGH, 1981, “Characterization of Astaxanthin Pigments from Heat-Processed Crawfish Waste’, J.
`Agric. Food Chem., 29: 505-508
`
`EYERS, 1977, “Using Crustacean Meals and Carotenoid-Fortified Diets”, Feedstuffs, Vol. 49(19)
`
`EYERS, 1994, “Developments in world aquaculture, feed formulations, and role of carotenoids”, Pure & Appl. Chem,
`ol. 66(5): 1069-1076
`
`ILLS et al., 1989, “Dietary N-6 and N-3 fatty acids and salt-induced hypertensionin the borderline hypertensiverat”,
`ipids, 24(1): 17-24
`
`OATES and VAN BENTEM, 1990, “Separating out the value”, Food Science and Technology Today, 4(4): 213-214
`
`ww~ao
`
`wco
`
`>>>awwWwNo=oS©
`
`>>oaa
`
`a
`
`IKOLAEVA, 1967 “Amino acid composition of protein-coagulatein krill’, VNIRO, 63:161-4
`
`PHLEGER,et al. (2002) “Interannual and between species comparisonin thelipids, fatty acids, and sterols of
`Antarctic krill from the US AMLR Elephant Island survey area: 1997 and 1998”. Comp Biochem Physiol 131B: 733-747
`
`POPP-SNIJDERSetal., 1987, “Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin
`sensitivity in non-insulin-dependent diabetes”, Diabetes Res. 4(3): 141-7
`
`SACHINDRA, 2006, “Recovery of carotenoids from shrimp wastein organic solvents”, Waste Management, 26:
`
`SAETHER etal., 1986, “Lipids of North Atlantic krill’, J Lipid Res., 27(3)-274-85.
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0408
`
`page 0408
`
`

`

` Attorney Docket Number
`
`15180439 - GAU: 1651
`(DAWL/
`Application Number
`
`
`Filing Date
`
`2016-06-13
`
` E
`
`
`
`
`
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. * Applicantis to place a check mark here if
`
`BOMIYA, 1982, “Yellow lens’ eyes of a stomiatoid deep-sea fish, Malacosteus niger’, Proc. R. Soc. Lond., 215:
`
`
`INFORMATION DISCLOSURE
`First Named Inventor|Inge Bruheim
`STATEMENT BY APPLICANT
`Art Unit
`( Not for submission under 37 CFR 1.99)
`Examiner Name
`
`| AKBM-14409/US-13/CON
`
`SHAHID! et al., 1998, “Carotenoid Pigments in Seafoods and Aquaculture” Critical Reviews in Food Science, 38(1):
`
`SIDEHU etal., 1970, “Biochmical Composition and Nutritive Value of Krill (Euphausia superb dana)”, J. Sci Food Agr.,
`
`SIMOPOULOS, 1991, “Omega-3 fatty acids in health and disease and in growth and development’, Am. Clin. Nutr.
`D4°438-63
`
`If you wish to add additional non-patentliterature documentcitation information please click the Add button
`
`EXAMINER SIGNATURE
`
`Examiner Signature
`
`
`
`*EXAMINER:Initial if reference considered, whetheror not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP $01.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). > For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial numberof the patent document.
`
`English language translation is attached.
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0409
`
`page 0409
`
`

`

`Application Number
` Attorney Docket Number
`
`Filing Date 2016-06-13
`
`INFORMATION DISCLOSURE First Named Inventor|Inge Bruheim
`
`STATEMENT BY APPLICANT
`|...
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`| AKBM-14409/US-13/CON
`
`
`
`cc
`
`IFOUGH
`
`/DW/
`
`15180439 - GAU: 1651
`
`
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection{s):
`
`CERTIFICATION STATEMENT
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`[-]
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three monthsprior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`See attachedcertification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`* Acertification statement is not submitted herewith.
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`Signature
`
` Name/Print
`
`2016-06-13
`
`
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public whichis to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0410
`
`page 0410
`
`
`
`

`

`Receipt date: 06/13/2016
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/D.W/
`
`15780439 - GAU: 1851
`
`Privacy Act Statement
`
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Departmentof Justice to determine whether the Freedom ofInformation Act requires disclosure of these record s.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence toa
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`requestinvolving an individual, to whom the record pertains, when the individual has requested assistance from the
`Memberwith respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSAaspart of that agency's responsibility to
`recommend improvements in records management practices and programs, underauthority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant(i.e., GSA or Commerce)directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record wasfiled in
`an application which became abandonedor in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`
`
`
`
`1.
`
`2.
`
`3.
`
`4,
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency,if the USPTO becomes aware ofa violation or potential violation of law or regulation.
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063 page 0411
`RIMFROST EXHIBIT 1063
`page 0411|
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Page 1 of 1
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`BIB DATA SHEET
`
`SERIAL NUMBER
`15/180,439
`
`FILINGor. 371(c)
`06/13/2016
`
`RULE
`
`APPLICANTS
`AKER BIOMARINE ANTARCTIC AS, Stamsund, NORWAY;
`
`INVENTORS
`Inge Bruheim, Volda, NORWAY;
`Snorre Tilseth, Bergen, NORWAY;
`Daniele Mancinelli, Orsta, NORWAY;
`
`CONFIRMATION NO. 4687
`
`GROUPARTUNIT ATTORNEY DOCKET
`AKBM-14409/US-13/CO
`
`RK FOREIGN APPLICATIONS KEEKEKREKERERERERERERERERER
`
`** IF REQUIRED, FOREIGN FILING LICENSE GRANTED **
`06/22/2016
`
`ves t4No
`Foreign Priority claimed
`35 USC 119(a-d) conditions met O Yes Wino
`Verified and
`/DEBBIE K WARE/
`Acknowledged
`Examiners signature
`
`C) Metafter|
`Thitials”
`
`RK CONTINUING DATA ERKKEKEEKERERERERERERERERER
`This application is a CON of 14/020,162 09/06/2013 PAT 9375453
`which is a CON of 12/057,775 03/28/2008 PAT 9034388
`which claims benefit of 60/920,483 03/28/2007
`and claims benefit of 60/975,058 09/25/2007
`and claims benefit of 60/983,446 10/29/2007
`and claims benefit of 61/024,072 01/28/2008
`
`
`
`STATE OR
`COUNTRY
`NORWAY
`
`SHEETS
`DRAWINGS
`19
`
`TOTAL
`CLAIMS
`20
`
`|INDEPENDENT
`CLAIMS
`2
`
`ADDRESS
`
`Casimir Jones, S.C.
`2275 DEMING WAY, SUITE 310
`MIDDLETON, WI 53562
`UNITED STATES
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`LJ All Fees
`
`LI 1.16 Fees(Filing)
`P
`in
`ven
`b
`has
`FEES: Authority
`been given in
`: Authority
`FILING FEE
`has
`Paper
`.
`,
`
`RECEIVED |No._———_stto. charge/credit DEPOSIT ACCOUNT 'O1.17Fees(ProcessingExt.oftime)|1.17 Fees (Processing Ext. of time)
`;
`for following:
`L) 1.18 Fees (Issue)
`
`L) Other
`
`LU Credit
`
`BIB (Rev. 05/07).
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0412
`
`page 0412
`
`

`

`Connecting via Winsock to SIN at pto-stn on port 23
`
`Welcome to STN International!
`
` Enter x:X
`
`LOGINID: ssspt189dxw
`
`
`PASSWORD:
`
`
` ENT
`TERMINAL (
`ER 1, 2, 3, OR ?):2
`
`Kk
`
`Kk KK Kk KK KKK
`
`Welcome to STN International
`
`kK
`
`Kk KK Kk
`
`kK
`
`ke kK
`
`NEWS
`
`1
`
`JAN 29
`
`Instructor-led and on-demand STN training options available
`from CAS
`
`
`
`
`
`4 APR 15
`
`£STN Express 8.6 Now Available
`JAN 11
`2
`3 MAR 23 Enhanced Coverage of Latin America (AR, MX)
`Patent Index
`USPATFULL/USPAT2 Now Include Corporate Patent Applicant
`Information
`
`
`
`
`
`in Derwent World
`
`
`
`
`
`
`
`
`
`MAY 22 Country Coverage in Derwent World Patent Index Extended to
`Include Turkey
`MAY 28 Partner with CAS to help shape the future of CAS products!
`JUL 2
`ajor Update to GBFULL Improves Quality of Full Text
`
`100 Millionth Small Molecule Added to CAS REGISTRY
`JUL 7
`
`SEP 15 New Version of Emtree Introduces over 800 New Terms to
`Embase on Classic STN and New STN
`
`
`
`
`
`
`
`
`
`NOV 25 Change to PI field in CAplus records
`
`JAN 11 PatentPak Now available to STN Express 8.6 and SIN on the
`Web customers
`
`JAN 11 CAplus Family of Files Updated with New Data to Support
`PatentPak in STN
`The Derwent World Patents Index (DWPI): Latest Manual Code
`Revision is now live
`
`JAN 14
`
`
`FEB 9
`
`15 MAR 23
`
`Emtree in Classic SIN Updated for 2016 with Additional
`Thesaurus Fields and Expanded Terminology
`
`CHEMLIST Content Expanded with the Addition of Information
`from Vermont
`
`
`
`APR 26 Data Quality Improved in CNFULL and FRFULL
`JUN 16 Latest New SIN Release Now Available
`
`
`
`
`
`NEWS
`NEWS
`
`NEWS
`
`NEWS
`NEWS
`NEWS
`NEWS
`
`NEWS
`NEWS
`
`NEWS
`
`NEWS
`
`NEWS
`
`NEWS
`
`NEWS
`NEWS
`
`NEWS
`
`NEWS
`
`5
`
`6
`7
`8
`9
`
`10
`11
`
`12
`
`13
`
`14
`
`16
`17
`
`18
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`JUN 24 May 2016 Update to Emtree in STN Provides Expanded
`Terminology for Biomedical and Pharmacological Searchers
`
`
`
`
`NEWS EXPRESS 21 MAR 2016 CURRENT WINDOWS VERSION IS V8.6,
`
`
`
`AND CURRENT DISCOVER FILE IS DATED 21 MAR 2016.
`
`
`
`NEWS HOURS
`NEWS
`LOGIN
`
`SIN Operating Hours Plus Help Desk Availability
`Welcome Banner and News Items
`
`NEWS TRAINING Find instructor-led and self-directed training opportunities
`
`
`Enter NEWS followed by the item number or name to see news on that
`specific topic.
`
`
`
`
`
`All use of STN is subject to the provisions of the SIN customer
`agreement.
`This agreement limits use to scientific research.
`for software development or design,
`implementation of commercial
`gateways,
`or use of CAS and STN data in the building of commercial
`products is prohibited and may result in loss of user privileges
`
`Use
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0413
`
`page 0413
`
`

`

`and other pena lties.
`
`Kk KK KKK KK KK KK KK
`
`KOK RK KK KKK KKK KK K STN Columbus
`
`
`
`
`
`FILE 'HOME' ENTERED AT 21:06:46 ON 09 JUL 2016
`
`
`=> index bioscience
`
`FILE 'WPIDS' ACCESS NOT AUTHORIZED
`
`
`
`FILE 'WPINDEX' ACCESS NOT AUTHORIZED
`COST IN U.S. DOLLARS
`
`
`
`FULL ESTIMATED COST
`
`
`
`
`
`
`
`
`
`INDEX 'ADISCTI, ADISINSIGHT, ADISNEWS, AGRICOLA, ANABSTR, BIOSIS, BIOTECHABS,
`
`
`
`
`BIOTECHDS, BIOTECHNO, CABA, CAPLUS, CEABA-VIB, CIN, CROPB, CROPU, DDFB,
`
`DDFU, DGENE, DISSABS, DRUGB, DRUGU, EMBAL, EMBASE, ESBIOBASE, FOMAD,
`
`
`
`FROSTI, FSTA, GENBANK,
`IFIALL,
`.' ENTERED AT 21:06:59 ON 09 JUL 2016
`
`
`
`
`
`46 FILES IN THE FILE LIST IN STNINDEX
`
`
`
`
`
`
`
`
`
`
`
`
`SINCE FILE
`
`ENTRY
`0.27
`
`TOTAL
`
`SESSION
`0.27
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Enter SET DETAIL ON to see search term postings or
`to view
`
`search error messages that display as 0* with SET DETAIL OFF.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`=> s krill and encpasul? and phospholipid and trimethyl(p)amine and astaxanthin
`
`
`
`FILE ADISNEWS
`O*
`
`
`FILE BIOTECHABS
`0*
`
`FILE BIOTECHDS
`O*
`0*
`FILE BIOTECHNO
`
`
`FILE CEABA-VTIB
`O*
`
`FILE CIN
`O*
`O*
`FILE FOMAD
`O*
`FILE FROSTI
`O*
`FILE KOSMET
`
`FILE NTIS
`O*
`O*
`FILE PASCAL
`
`
`42 FILES SEARCHED.
`
`
`Q FILES HAVE ONE OR MORE ANSWERS,
`
`Li
`
`
`
`QUE KRILL AND ENCPASUL? AND PHOSPHOLIPID AND TRIMETHYL(P) AMINE AND ASTAXA
`NTHIN
`
`
`
`
`46 FILES SEARCHED IN STNINDEX
`
`
`
`
`
`
`
`=> s krill(p)oil and phospholipid? and trimethyl(p)amine and astaxanthin
`
`
`
`FILE ADISNEWS
`O*
`
`
`
`FILE BIOTECHABS
`0*
`
`FILE BIOTECHDS
`O*
`0*
`FILE BIOTECHNO
`
`FILE CAPLUS
`2
`
`
`FILE CEABA-VTIB
`O*
`
`FILE CIN
`O*
`O*
`FILE FOMAD
`O*
`FILE FROSTI
`
`FILE IFIALL
`2
`
`
`
`
`30 FILES SEARCHED...
`O*
`FILE KOSMET
`
`FILE NTIS
`O*
`
`
`FILE PASCAL
`O*
`FILE USPATFULL
`15
`4
`FILE USPAT2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4 FILES HAVE ONE OR MORE ANSWERS,
`
`
`
`
`
`
`
`46 FILES SEARCHED IN STNINDEX
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0414
`
`page 0414
`
`

`

`L2
`
`
`
`QUE KRILL(P) OIL AND PHOSPHOLIPID? AND TRIMETHYL(P) AMINE AND ASTAXANTHIN
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`=> file uspat2 usptfull ifiall caplus
`
`
`
`
`'USPTFULL'
`IS NOT A VALID FILE NAME
`
`
`for a list of files
`(=>)
`Enter "HELP FILE NAMES" at an arrow prompt
`that are available.
`If you have requested multiple files, you can
`specify a corrected file name or you can enter "IGNORE" to continue
`accessing the remaining file names entered.
`
`ENTER A FILE NAME OR (IGNORE):.
`COST IN U.S. DOLLARS
`
`
`
`FULL ESTIMATED COST
`
`FILE 'USPAT2' ENTERED AT 21:08:51 ON 09 JUL 2016
`
`
`
`CA INDEXING COPYRIGHT (C) 2016 AMERICAN CHEMICAL SOCIETY (ACS)
`
`FILE 'IFIALL' ENTERED AT 21:08:51 ON 09 JUL 2016
`COPYRIGHT (C) 2016 IFI CLAIMS(R) Patent Services (IFI)
`
`
`FILE 'CAPLUS' ENTERED AT 21:08:51 ON 09 JUL 2016
`
`
`
`
`
`
`
`USE IS SUBJECT TO THE TERMS OF YOUR STN CUSTOMER AGREEMENT.
`
`
`
`COPYRIGHT (C) 2016 AMERICAN CHEMICAL SOCIETY (ACS)
`
`
`
`
`
`
`
`SINCE FILE
`
`ENTRY
`2.91
`
`TOTAL
`
`SESSION
`3.18
`
`
`
`
`
`
`
`=> s L2
`L3
`
`8 L2
`
`
`
`=> dup rem L3
`
`
`
`PROCESSING COMPLETED FOR L3
`
`8 DUP REM L3
`L4
`
`
`
`
`
`
`
`
`(0 DUPLICATES REMOVED)
`
`=> d L4 1-8
`
`ANSWER 1 OF 8
`2014:304518
`
`
`
`USPAT2 on STN
` USPAT2
`
`
`
`
`
`
`
`L4
`AN
`
`TI
`
`CPC
`
`
`
`
`
`
`
`Formulations of water-soluble derivatives of vitamin E and compositions
`
`containing same
`
`Bromley, Philip J., Fullerton, CA, UNITED STATES
`IN
`
`Inc., Walnut, CA, UNITED STATES (U.S. corporation)
`Virun,
`PA
`
`20160531
`B2
`US 9351517
`PI
`US 2014-14207310
`20140312 (14)
`AI
`US 2013-61852243
`20130315 (61)
`PRAI
`
`Utility
`DT
`GRANTED
`FS
`LN.CNT 12112
`NCL
`NCLM:
`NCLS:
`CPCI
`
`424/094.100
`426/072.000; 514/458.000; 514/690.000
`A23L0002-52 [I]; A61K0031-355 [I]; A61K0031-122 [I]; A61K0031-202
`[I]; A61K0031-355 [I], A61K2300-00; A61K0031-202 [TIT],
`A61K2300-00; A61K0031-201 [I], A61K2300-00; A61K0031-122 [TI],
`A61K2300-00; A61K0031-05 [I], A61K2300-00; A61K0031-59 [T],
`A61K2300-00
`CPCI-2 A23L0002-52 [I]; A23L0001-30 [I]; A23L0001-3002 [I]; A23L0001-302
`[I]; A23L0001-304 [I]; A23L0001-3006 [I]; A23L0001-3008 [I];
`A23L0002-02 [I]; A23L0002-60 [1]; A61K0009-0095 [I];
`A61K0009-1075 [1]; A61K0031-05 [I]; A61K0031-122 [I];
`A61K0031-201 [I]; A61K0031-202 [I]; A61K0031-355 [I]; A61K0031-59
`[I]; A61K0047-36 [I]; Ao1K0047-44 [1]; A61K0031-355 [I],
`A61K2300-00; A61K0031-202 [I], A61K2300-00; A61K0031-201 [T],
`A61K2300-00; A61K0031-122 [I], A61K2300-00; A61K0031-05 [TI],
`A61K2300-00; A61K0031-59 [I], A61K2300-00
`A23L0002-52 [I]; A61K0031-122 [I]; A61K0031-202 [I]; A61K0031-355
`
`
`
`[I
`
`
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0415
`
`page 0415
`
`IPC
`
`IPCI
`
`

`

`IPCI-2 A61K0038-43 [1]; A23L0002-52 [I]; A61K0031-355 [1]; A61K0031-122
`[I]; A61K0031-202 [I]; A23L0001-30 [I]; A23L0001-302 [I];
`A23L0001-304 [I]; A23L0002-02 [I]; A23L0002-60 [I]; A61K0031-05
`[I]; A61K0031-201 [1]; A61K0031-59 [I]; A61K0009-00 [TI];
`A61K0047-36 [I]; A61K0009-107 [1]; A61K0047-44 [T]
`A23L0002-52 [I]; A61K0031-122 [1]; A61K0031-202 [I]; A61K0031-355
`[I]
`
`IPCR
`
`
`
`
`ANSWER 2 OF 8
`2013:254433
`
`USPAT2 on STN
`USPAT2
`
`
`
`Reduced fluoride crustacean oil compositions
`Bruheim,
`Inge, Volda, NORWAY
`
`Griinari, Mikko, Espoo, FINLAND
`Remoy, Stig Rune, Fosnavaag, NORWAY
`
`OLYMPIC SEAFOOD AS, NORWAY (non-U.S. corporation)
`
`US 9068142
`B2
`20150630
`US 2013-13856642
`20130404 (13)
`Division of Ser. No. US 2012-13342664, filed on 3 Jan 2012, Pat. No. US
`
`8557297 Continuation of Ser. No. US 1900-63488, PENDING A 371 of
`International Ser. No. WO 2009-NO322, filed on 14 Sep 2009
`NO 2008-3906
`20080912
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`COPYRIGHT 2016 IFI on STN
`
`
`
`(NO); Remoy Stig
`
`
`
`
`
`
`
`
`
`L4
`AN
`
`TI
`IN
`
`PA
`PI
`AI
`RLI
`
`PRAI
`
`CPC
`
`IPC
`
`L4
`AN
`TI
`
`IN
`
`PA
`PPA
`PI
`AI
`
`RLI
`FI
`
`Utility
`DT
`GRANTED
`FS
`LN.CNT 1416
`001/001.000; 530/359.000
`NCL
`NCLM:
`530/350.000; 554/078.000
`NCLS:
`[I]; CO7K0014-43509 [T]
`C11B0003-006 [I]; CO7K0019-00
`CPCI
`[I]; A23L0001-3053 [I];
`CPCI-2 C11B0003-006 [I]; A23L0001-0153
`A23L0001-33 [I]; A23L0001-3006 [I]; A23L0001-3252 [I];
`A23D0009-013 [I]; A23J0001-04
`[I]; A23L0001-0152 [I];
`CO7K0014-43509 [I]; CO7K0019-00
`[I]; A23J0003-34 [I];
`A23D0009-007 [I]; A23D0009-02
`[1]; C11B0001-10 [I]; C11B0001-104
`[I]; C11B0001-025 [T]
`[I]; CO7K0019-00 [T]
`C11B0003-00
`[I]; CO7K0014-435
`IPCI
`IPCI-2 CO7K0001-00
`[I]; C11B0003-00 [I]; A23L0001-015 [I]; A23L0001-305
`[I]; A23L0001-33 [I]; A23L0001-30 [I]; A23L0001-325 [I];
`A23D0009-013 [I]; A23J70001-04
`[I]; CO7K0014-435 [I]; C0O7K0019-00
`[I]; A23J0003-34 [I]; A23D0009-007 [I]; A23D0009-02 [I];
`C11B0001-10
`[I]; C11B0001-02 [T]
`CO7KO001-00
`[I]; A23D0009-007
`[I]; A23D0009-013 [I]; A23D0009-02
`[I]; A2370001-04 [I]; A23J0003-34 [I]; A23L0001-015 [I];
`A23L0001-30
`[I]; A23L0001-305
`[I]; A23L0001-325 [I]; A23L0001-33
`
`[I]; CO7K0014-435 [1]; CO7K0019-00 [I]; C11B0001-02 [I];
`[I]; C11B0003-00 [TI]
`C11B0001-10
`
`
`
`CAS INDEXING IS AVAILABLE FOR THIS PATENT.
`
`IPCR
`
`
`
`
`
`
`
`
`
`
`ANSWER 3 OF 8
`IFIALL
`
`
`14080750
`IFIALL
`
`
`
`
`ETHOD FOR PROCESSING CRUSTACEANS TO PRODUCE LOW FLUORIDE/LOW TRIMETHYL
`AMINE PRODUCTS THEREOF
`
`Bruheim Inge (NO); Griinari Mikko (FI); Ervik Jon Reidar
`Rune
`(NO); Remoy Even (NO); Cameron John (NO)
`Unassigned or assigned to individual
`(68000)
`Olympic Seafood As; Rimfrost As
`(Probable)
`US 20150030751 Al
`20150129
`US 2012-370324
`20121221
`
`WO 2012-IB3004
`20121221
`PCT 371 date
`20140702
`PCT 102(e) date
`20140702
`20120103 CONTINUATION-IN-PART
`20150129
`
`US 2012-342664
`US 20150030751
`US 8557297
`
`(14)
`
`
`
`8557297
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0416
`
`page 0416
`
`

`

`
`
`CLMN
`
`L4
`AN
`
`TI
`IN
`
`PA
`
`PI
`AI
`RLI
`
`
`
`ANSWER 4 OF 8
`2012:168278
`
`
`
`USPAT2 on STN
`USPAT2
`
`
`
`
`B2
`
`
`
`
`
`
`
`
`DT
`FS
`
`ED
`
`Utility; Patent Application - First Publication
`CHEMICAL
`APPLICATION
`Entered STN: 30 Jan 2015
`
`Last Updated on STN: 20 Nov 2015
`25
`
`ethod for processing crustaceans and products thereof
`Bruheim,
`Inge, Volda, NORWAY
`
`Griinari, Mikko, Espoo, FINLAND
`Ervik, Jon Reidar, Aalesund, NORWAY
`
`Remoy, Stig Rune, Fosnavag, NORWAY
`
`
`
`
`
`
`Olympic Se